Although normal or PTEN-WT breast tumors do not depend on p110 β isoform activity in PI3K signaling, cancer cells with PTEN deficiency require p110β activity to sustain PI3K signaling and are sensitized to PI3Kβ-specific inhibition (Torbett et al., 2008). Here, PIK3CB is linked to cancer.